Barton Russell Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$29,472.41

Insider Activity of Barton Russell

According to the SEC Form 4 filings, Barton Russell, being in a position of

  1. Chief Operating Officer at Acumen Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 15625 shares for $29,917,
    over all time since 2024-01-18, has bought 0 shares, and sold 29008 shares for $59,390.

Biography of Barton Russell

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $29,9176100

Comparison of Insiders on Amount of Buys and Sells

2026-01-22SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
462
0.0007%
$1.84$850+26.13%
2026-01-21SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
2,315
0.0038%
$1.81$4,181+38.67%
2026-01-08SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
3,530
0.0058%
$1.86$6,562+33.6%
2026-01-07SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
1,700
0.0028%
$1.99$3,378+24.62%
2026-01-06SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
3,618
0.0059%
$1.97$7,114+26.53%
2026-01-05SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
4,000
0.0065%
$1.96$7,832+25.25%
2025-01-21SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
2,914
0.0047%
$1.61$4,692-14.72%
2025-01-03SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
7,636
0.0125%
$1.86$14,225-26.84%
2024-01-18SaleAcumen Pharmaceuticals, Inc.
ABOS
Chief Operating Officer
2,833
0.005%
$3.73$10,555-23.1%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.